Key result
Phenotypic frailty without multimorbidity increased 18-year mortality risk similarly to multimorbidity without frailty, while their combination strongly predicted mortality.
Why the study?
Multimorbidity, prefrailty, and frailty are frequent in ageing populations, but their independent relationships to long-term prognosis in home-dwelling older people are not well recognised.
Does phenotypic frailty and multimorbidity predict 18-year mortality in home-dwelling older men?
Cohort (n=1,365)
No
Does phenotypic frailty and multimorbidity predict 18-year mortality in home-dwelling older men?
Phenotypic frailty alone is associated with a similar long-term mortality risk as multimorbidity in older men, and their combination synergistically increases mortality risk.
Answers are grounded in this paper and cite their sources.
May inform long-term risk stratification in older men; leaves open whether frailty-targeted interventions improve survival.
PURPOSE: Multimorbidity, prefrailty, and frailty are frequent in ageing populations, but their independent relationships to long-term prognosis in home-dwelling older people are not well recognised. METHODS: In the Helsinki Businessmen Study (HBS) men with high socioeconomic status (born 1919-1934, n = 3490) have been followed-up from midlife. In 2000, multimorbidity (≥ 2 conditions), phenotypic prefrailty and frailty were determined in 1365 home-dwelling men with median age of 73 years). Disability was assessed as a possible confounder. 18-year mortality follow-up was established from registers and Cox regression used for analyses. RESULTS: Of the men, 433 (31.7%) were nonfrail and without multimorbidity at baseline (reference group), 500 (36.6%) and 82 (6.0%) men had prefrailty or frailty, respectively, without multimorbidity, 84 (6.2%) men had multimorbidity only, and 201 (14.7%) and 65 (4.8%) men had prefrailty or frailty together with multimorbidity. Only 30 (2.2%) and 86 (6.3%) showed signs of ADL or mobility disability. In the fully adjusted analyses (including ADL disability, mental and cognitive status) of 18-year mortality, frailty without multimorbidity (hazard ratio 1.62, 95% confidence interval 1.13-2.31) was associated with similar mortality risk than multimorbidity without frailty (1.55, 1.17-2.06). The presence of both frailty and multimorbidity indicated a strong mortality risk (2.93, 2.10-4.07). CONCLUSION: Although multimorbidity is generally considered a substantial health problem, our long-term observational study emphasises that phenotypic frailty alone, independently of disability, may be associated with a similar risk, and a combination of multimorbidity and frailty is an especially strong predictor of mortality.
No takes yet. Share an insight, caveat, or question.
Strandberg et al. (2021) conducted a cohort in Older home-dwelling men (n=1,365). Phenotypic frailty without multimorbidity vs. No prefrailty/frailty and no multimorbidity was evaluated on 18-year mortality (HR 1.62, 95% CI 1.13-2.31). Phenotypic frailty without multimorbidity increased 18-year mortality risk similarly to multimorbidity without frailty, while their combination strongly predicted mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: